E. Kostova-Dimitrova
Research Subjects
E. Kostova-Dimitrova has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Alexandrov
National Heart Hospital -Sofi a Резюме
2 shared publications - Georgi Vladimirov
National Heart Hospital -Sofi a Резюме
2 shared publications - Hristo Mateev
Interventional Cardiology Department National Heart Hospital MU-Sofia Sofia Bulgaria
2 shared publications - Elena Dimitrova
National Cardiology Hospital Sofia, 1309 Sofia, Bulgaria
1 shared publication - Elina Trendafilova
National Heart Hospital, Sofia, Bulgaria
1 shared publication G. Hristova
National Heart Hospital -Sofi a Резюме
1 shared publication
Latest Publications
- Open Access
- 7 April 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (1) , 86-93
Percutaneous coronary interventions in patients over 80 years old age with acute coronary syndrome
Age is an important non-modifi able risk factor for cardiovascular disease. Both European and American guidelines recommend offering an invasive reperfusion strategy in elderly patients with ACS, taking into account the patients‘ comorbidities and baseline level of functioning. Materials and methods: All patients over 80 years of age with acute coronary syndrome, treated in the Department of Invasive Cardiology of the National Heart Hospital for the period between January 1, 2016. and December 31, 2018, are retrospectively analyzed. The primary endpoint was defi ned as all-cause mortality during the hospital stay and at follow-up. Predictors of mortality were assessed and independent predictors were identifi ed. Results: During the study period, 179 patients aged 80 years or older were identifi ed as being treated for ACS with PCI. In the study population, in hospital mortality for the index event was 11.8%. At a mean follow-up time of 20.19 ± 11.9 months, mortality rose signifi cantly to 64.6%. When evaluating in-hospital mortality on multivariate analysis, the two independent predictors were Cardiogenic shock (HR 0.005, 95% CI 0.01–0.44; p < 0.001) and acute/exacerbated renal failure (0.986 95% CI 0.984-0.997; p = 0.015). Conclusion: The present study provides important information regarding characteristics and outcomes in very elderly patients undergoing PCI for ACS. In the future, this subset of patients is predicted to grow, meaning that their approach must be evidence-based to ensure safe and effective treatment options.
- 7 April 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (1) , 86-93
Open AccessPercutaneous coronary interventions in patients over 80 years old age with acute coronary syndrome
Age is an important non-modifi able risk factor for cardiovascular disease. Both European and American guidelines recommend offering an invasive reperfusion strategy in elderly patients with ACS, taking into account the patients‘ comorbidities and baseline level of functioning. Materials and methods: All patients over 80 years of age with acute coronary syndrome, treated in the Department of Invasive Cardiology of the National Heart Hospital for the period between January 1, 2016. and December 31, 2018, are retrospectively analyzed. The primary endpoint was defi ned as all-cause mortality during the hospital stay and at follow-up. Predictors of mortality were assessed and independent predictors were identifi ed. Results: During the study period, 179 patients aged 80 years or older were identifi ed as being treated for ACS with PCI. In the study population, in hospital mortality for the index event was 11.8%. At a mean follow-up time of 20.19 ± 11.9 months, mortality rose signifi cantly to 64.6%. When evaluating in-hospital mortality on multivariate analysis, the two independent predictors were Cardiogenic shock (HR 0.005, 95% CI 0.01–0.44; p < 0.001) and acute/exacerbated renal failure (0.986 95% CI 0.984-0.997; p = 0.015). Conclusion: The present study provides important information regarding characteristics and outcomes in very elderly patients undergoing PCI for ACS. In the future, this subset of patients is predicted to grow, meaning that their approach must be evidence-based to ensure safe and effective treatment options.
- Open Access
- 7 April 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (1) , 50-64
Impact of the COVID-19 pandemic on the incidence and prognosis of acute myocardial infarction - a single-center restrospective analysis
Въведение: COVID-19 пандемията доведе до значима промяна в честотата и прогнозата на острия миокарден инфаркт (ОМИ) по индиректни и директни механизми. Цел: Да се оцени влиянието на COVID-19 пандемията върху честотата и прогнозата на ОМИ. Материал и методи: Направихме ретроспективен анализ на последователни пациенти с ОМИ (STEMI и NSTEMI) през два периода – извънредното положение и една от вълните на пандемията. Сравнихме рисковия им профил, протичането на индексното събитие, проведените изследвания и лечение с контролна група от периода преди пандемията. Резултати: През първия период включихме 52 пациенти с ОМИ без COVID-19 инфекция, които сравнихме с контролна група от 66 пациенти. Отчетохме намаляване на броя предимно на пациентите със STEMI. Скоровете за тежест на състоянието (GRACE, APACHE II, SOFA) са достоверно по-високи през 2020 спрямо преди пандемията. Повече пациенти постъпват с прояви на остра застойна сърдечна недостатъчност, няма разлика в смъртността. През втория период включихме 83 пациенти, 21 от които с COVID–19 инфекция. Отчетохме сигнификантно нарастване на забавянето от страна на системата при всички пациенти. Скоровете за тежест и изходният тропонин са достоверно по-високи през този период. Наблюдава се значимо увеличаване на вътреболничната смъртност в групата с COVID–19 спрямо контролната група (23,8% спрямо 9%, р = 0,0375), вероятно поради увеличената честота на кардиогенния шок и на необходимостта от апаратна вентилация. Заключение: По време на извънредното положение отчетохме намаляване на броя пациенти с ОМИ, както и повишена честота на остра застойна сърдечна недостатъчност без увеличаване на смъртността. По време на една от вълните на COVID-19 пандемията установихме достоверно увеличаване на забавянето от страна на системата, което не надвишава препоръчителния интервал от 120 минути, и на тежестта на състоянието на всички пациенти. Наличието на COVID-19 инфекция се свързва с увеличена вътреболничната смъртност за сметка на увеличена честота на кардиогенния шок и необходимостта от апаратна вентилация. Introduction: COVID-19 pandemic has led to a signifi cant change in the incidence and prognosis of acute myocardial infarction (AMI) by indirect and direct mechanisms. Aim: To assess the impact of the COVID-19 pandemic on the incidence and prognosis of AMI. Material and methods: We performed a retrospective analysis of consecutive patients with AMI (STEMI and NSTEMI) during two time periods – the complete lockdown in Bulgaria and one of the waves of the pandemic. We compared patients’ risk profi le, index event, investigations and treatment to a control group from the pre-pandemic period. Results: During the fi rst period we included 52 patients with AMI without COVID-19 and compared them to a control group of 66 patients. We found a decrease primarily in the number of patients with STEMI. The scores for assessing diseaseseverity (GRACE, APACHE II, SOFA) were higher in 2020 compared to the pre-pandemic period. More patients presented with acute congestive heart failure, mortality was similar. During the second period we included 83 patients, 21 of them with COVID-19 infection. System delay was increased in all patients. Disease severity scores and baseline troponin were higher especially in the COVID-19 group. In-hospital mortality was substantially higher in patients with COVID-19 compared to controls (23,8% versus 9%, р = 0,0375), probably due to increased incidence of cardiogenic shock and need for mechanical ventilation. Conclusion: During the complete lockdown there was a reduction in the number of patients admitted with AMI, higher incidence of acute congestive heart failure and similar mortality. During one of the waves of the pandemic we found a signifi cant increase in system delay, not exceeding the recommended time frame of 120 minutes, and in disease severity in all patients. Concomitant COVID-19 infection was associated with higher in-hospital mortality due to increased incidence of cardiogenic shock and need for mechanical ventilation.
- 7 April 2023
- Published by Pensoft Publishers in Bulgarian Cardiology
- Vol. 29 (1) , 50-64
Open AccessImpact of the COVID-19 pandemic on the incidence and prognosis of acute myocardial infarction - a single-center restrospective analysis
Въведение: COVID-19 пандемията доведе до значима промяна в честотата и прогнозата на острия миокарден инфаркт (ОМИ) по индиректни и директни механизми. Цел: Да се оцени влиянието на COVID-19 пандемията върху честотата и прогнозата на ОМИ. Материал и методи: Направихме ретроспективен анализ на последователни пациенти с ОМИ (STEMI и NSTEMI) през два периода – извънредното положение и една от вълните на пандемията. Сравнихме рисковия им профил, протичането на индексното събитие, проведените изследвания и лечение с контролна група от периода преди пандемията. Резултати: През първия период включихме 52 пациенти с ОМИ без COVID-19 инфекция, които сравнихме с контролна група от 66 пациенти. Отчетохме намаляване на броя предимно на пациентите със STEMI. Скоровете за тежест на състоянието (GRACE, APACHE II, SOFA) са достоверно по-високи през 2020 спрямо преди пандемията. Повече пациенти постъпват с прояви на остра застойна сърдечна недостатъчност, няма разлика в смъртността. През втория период включихме 83 пациенти, 21 от които с COVID–19 инфекция. Отчетохме сигнификантно нарастване на забавянето от страна на системата при всички пациенти. Скоровете за тежест и изходният тропонин са достоверно по-високи през този период. Наблюдава се значимо увеличаване на вътреболничната смъртност в групата с COVID–19 спрямо контролната група (23,8% спрямо 9%, р = 0,0375), вероятно поради увеличената честота на кардиогенния шок и на необходимостта от апаратна вентилация. Заключение: По време на извънредното положение отчетохме намаляване на броя пациенти с ОМИ, както и повишена честота на остра застойна сърдечна недостатъчност без увеличаване на смъртността. По време на една от вълните на COVID-19 пандемията установихме достоверно увеличаване на забавянето от страна на системата, което не надвишава препоръчителния интервал от 120 минути, и на тежестта на състоянието на всички пациенти. Наличието на COVID-19 инфекция се свързва с увеличена вътреболничната смъртност за сметка на увеличена честота на кардиогенния шок и необходимостта от апаратна вентилация. Introduction: COVID-19 pandemic has led to a signifi cant change in the incidence and prognosis of acute myocardial infarction (AMI) by indirect and direct mechanisms. Aim: To assess the impact of the COVID-19 pandemic on the incidence and prognosis of AMI. Material and methods: We performed a retrospective analysis of consecutive patients with AMI (STEMI and NSTEMI) during two time periods – the complete lockdown in Bulgaria and one of the waves of the pandemic. We compared patients’ risk profi le, index event, investigations and treatment to a control group from the pre-pandemic period. Results: During the fi rst period we included 52 patients with AMI without COVID-19 and compared them to a control group of 66 patients. We found a decrease primarily in the number of patients with STEMI. The scores for assessing diseaseseverity (GRACE, APACHE II, SOFA) were higher in 2020 compared to the pre-pandemic period. More patients presented with acute congestive heart failure, mortality was similar. During the second period we included 83 patients, 21 of them with COVID-19 infection. System delay was increased in all patients. Disease severity scores and baseline troponin were higher especially in the COVID-19 group. In-hospital mortality was substantially higher in patients with COVID-19 compared to controls (23,8% versus 9%, р = 0,0375), probably due to increased incidence of cardiogenic shock and need for mechanical ventilation. Conclusion: During the complete lockdown there was a reduction in the number of patients admitted with AMI, higher incidence of acute congestive heart failure and similar mortality. During one of the waves of the pandemic we found a signifi cant increase in system delay, not exceeding the recommended time frame of 120 minutes, and in disease severity in all patients. Concomitant COVID-19 infection was associated with higher in-hospital mortality due to increased incidence of cardiogenic shock and need for mechanical ventilation.